963 results on '"White, Michel"'
Search Results
2. COVID-19 anxiety, psychological well-being and preventive behaviors during the COVID-19 pandemic in Latin America and the Caribbean: relationships and explanatory model
3. Prevalence and Predictors of Intention to be Vaccinated Against COVID-19 in Thirteen Latin American and Caribbean Countries
4. Cross-cultural validation of the new version of the Coronavirus Anxiety Scale in twelve Latin American countries
5. An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol
6. Is the meaning of subjective well-being similar in Latin American countries? A cross-cultural measurement invariance study of the WHO-5 well-being index during the COVID-19 pandemic
7. Low-Density Neutrophils and Neutrophil Extracellular Traps (NETs) Are New Inflammatory Players in Heart Failure
8. Abstract 15269: Effect of a Systemic Right Ventricle With A Biventricular Circulation on Cardiorespiratory Fitness
9. Design of the Prospective Comparison of Angiotensin Receptor-Neprilysin Inhibitor vs Placebo in Patients With Congenital Systemic Right Ventricular Heart Failure Trial (PARACYS-RV)
10. Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes
11. Regulatory T Cell Biomarkers Identify Patients at Risk of Developing Acute Cellular Rejection in the First Year Following Heart Transplantation
12. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
13. Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
14. Similar clinical benefits from below‐target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial
15. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
16. Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial
17. Low-Density Neutrophils Contribute to Subclinical Inflammation in Patients with Type 2 Diabetes
18. Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study
19. Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
20. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone
21. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure
22. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure
23. Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations?
24. HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients
25. Navigating Informed Consent Requirements and Expectations in Cluster Randomized Trials: Research Ethics Board Members’ and Researchers’ Views
26. Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
27. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.
28. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial
29. Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype
30. Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation
31. Subclinical Inflammation in Heart Failure: A Neutrophil Perspective
32. A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial
33. Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac Transplantation
34. Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?
35. Automated E-Counseling for Chronic Heart Failure: CHF-CePPORT Trial
36. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation
37. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial
38. Effects Of Colchicine On Inflammation, Myocardial Damage And Microvascular Dysfunction In Men And Women With Heart Failure With Preserved Ejection Fraction
39. Effects of reading media on reading comprehension in health professional education: a systematic review protocol
40. Abstract 17121: Initiation of Anti-Hypertensive Therapy and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and a History of Hypertension (HTN)
41. Abstract 16422: Lower Mitochondrial-derived Peptide Humanin in Young Adults Born Preterm vs. Term and Association With Left Ventricular Ejection Fraction
42. Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study
43. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone
44. Hyperventilation-induced heart rate response as a potential marker for cardiovascular disease
45. COVID-19 Bereavement in Ten Latin American Countries: Measurement Invariance of the Pandemic Grief Scale and Its Relation to Suicidal Ideation.
46. Experience with the SynCardia total artificial heart in a Canadian centre
47. Changes in patient characteristics following cardiac transplantation: the Montreal Heart Institute experience
48. EFFECTS OF COLCHICINE ON INFLAMMATION AND MICROVASCULAR DYSFUNCTION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
49. Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
50. Cerebral Hemodynamics During Exercise and Recovery in Heart Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.